Copyright Reports & Markets. All rights reserved.

Global Dermal filler and Botolinum Toxin Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Dermal filler and Botolinum Toxin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Dermal filler and Botolinum Toxin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Dermal filler and Botolinum Toxin Market Size Growth Rate by Type
    • 1.4.2 Aesthetic Volume Restoration
    • 1.4.3 Wrinkle Reduction
  • 1.5 Market by Application
    • 1.5.1 Global Dermal filler and Botolinum Toxin Market Size Growth Rate by Application
    • 1.5.2 Hyaluronic Acid Based Fillers
    • 1.5.3 Non-Hyaluronic Acid Based Fillers
    • 1.5.4 Botulinum Toxin
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Dermal filler and Botolinum Toxin Market Size, Estimates and Forecasts
    • 2.1.1 Global Dermal filler and Botolinum Toxin Revenue 2015-2026
    • 2.1.2 Global Dermal filler and Botolinum Toxin Sales 2015-2026
  • 2.2 Global Dermal filler and Botolinum Toxin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Dermal filler and Botolinum Toxin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Dermal filler and Botolinum Toxin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Dermal filler and Botolinum Toxin Competitor Landscape by Players

  • 3.1 Dermal filler and Botolinum Toxin Sales by Manufacturers
    • 3.1.1 Dermal filler and Botolinum Toxin Sales by Manufacturers (2015-2020)
    • 3.1.2 Dermal filler and Botolinum Toxin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Dermal filler and Botolinum Toxin Revenue by Manufacturers
    • 3.2.1 Dermal filler and Botolinum Toxin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Dermal filler and Botolinum Toxin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Dermal filler and Botolinum Toxin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Dermal filler and Botolinum Toxin Revenue in 2019
    • 3.2.5 Global Dermal filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Dermal filler and Botolinum Toxin Price by Manufacturers
  • 3.4 Dermal filler and Botolinum Toxin Manufacturing Base Distribution, Product Types
    • 3.4.1 Dermal filler and Botolinum Toxin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Dermal filler and Botolinum Toxin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Dermal filler and Botolinum Toxin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Dermal filler and Botolinum Toxin Market Size by Type (2015-2020)
    • 4.1.1 Global Dermal filler and Botolinum Toxin Sales by Type (2015-2020)
    • 4.1.2 Global Dermal filler and Botolinum Toxin Revenue by Type (2015-2020)
    • 4.1.3 Dermal filler and Botolinum Toxin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Dermal filler and Botolinum Toxin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Dermal filler and Botolinum Toxin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Dermal filler and Botolinum Toxin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Dermal filler and Botolinum Toxin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Dermal filler and Botolinum Toxin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Dermal filler and Botolinum Toxin Market Size by Application (2015-2020)
    • 5.1.1 Global Dermal filler and Botolinum Toxin Sales by Application (2015-2020)
    • 5.1.2 Global Dermal filler and Botolinum Toxin Revenue by Application (2015-2020)
    • 5.1.3 Dermal filler and Botolinum Toxin Price by Application (2015-2020)
  • 5.2 Dermal filler and Botolinum Toxin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Dermal filler and Botolinum Toxin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Dermal filler and Botolinum Toxin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Dermal filler and Botolinum Toxin Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Dermal filler and Botolinum Toxin by Country
    • 6.1.1 North America Dermal filler and Botolinum Toxin Sales by Country
    • 6.1.2 North America Dermal filler and Botolinum Toxin Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Dermal filler and Botolinum Toxin Market Facts & Figures by Type
  • 6.3 North America Dermal filler and Botolinum Toxin Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Dermal filler and Botolinum Toxin by Country
    • 7.1.1 Europe Dermal filler and Botolinum Toxin Sales by Country
    • 7.1.2 Europe Dermal filler and Botolinum Toxin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Dermal filler and Botolinum Toxin Market Facts & Figures by Type
  • 7.3 Europe Dermal filler and Botolinum Toxin Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Dermal filler and Botolinum Toxin by Region
    • 8.1.1 Asia Pacific Dermal filler and Botolinum Toxin Sales by Region
    • 8.1.2 Asia Pacific Dermal filler and Botolinum Toxin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Dermal filler and Botolinum Toxin Market Facts & Figures by Type
  • 8.3 Asia Pacific Dermal filler and Botolinum Toxin Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Dermal filler and Botolinum Toxin by Country
    • 9.1.1 Latin America Dermal filler and Botolinum Toxin Sales by Country
    • 9.1.2 Latin America Dermal filler and Botolinum Toxin Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Dermal filler and Botolinum Toxin Market Facts & Figures by Type
  • 9.3 Central & South America Dermal filler and Botolinum Toxin Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Dermal filler and Botolinum Toxin by Country
    • 10.1.1 Middle East and Africa Dermal filler and Botolinum Toxin Sales by Country
    • 10.1.2 Middle East and Africa Dermal filler and Botolinum Toxin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Dermal filler and Botolinum Toxin Market Facts & Figures by Type
  • 10.3 Middle East and Africa Dermal filler and Botolinum Toxin Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Allergan
    • 11.1.1 Allergan Corporation Information
    • 11.1.2 Allergan Description and Business Overview
    • 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Allergan Dermal filler and Botolinum Toxin Products Offered
    • 11.1.5 Allergan Related Developments
  • 11.2 Galderma
    • 11.2.1 Galderma Corporation Information
    • 11.2.2 Galderma Description and Business Overview
    • 11.2.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Galderma Dermal filler and Botolinum Toxin Products Offered
    • 11.2.5 Galderma Related Developments
  • 11.3 Merz Pharma GmbH & Co. KGaA
    • 11.3.1 Merz Pharma GmbH & Co. KGaA Corporation Information
    • 11.3.2 Merz Pharma GmbH & Co. KGaA Description and Business Overview
    • 11.3.3 Merz Pharma GmbH & Co. KGaA Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merz Pharma GmbH & Co. KGaA Dermal filler and Botolinum Toxin Products Offered
    • 11.3.5 Merz Pharma GmbH & Co. KGaA Related Developments
  • 11.4 Anika Therapeutics
    • 11.4.1 Anika Therapeutics Corporation Information
    • 11.4.2 Anika Therapeutics Description and Business Overview
    • 11.4.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Anika Therapeutics Dermal filler and Botolinum Toxin Products Offered
    • 11.4.5 Anika Therapeutics Related Developments
  • 11.5 Suneva Medical
    • 11.5.1 Suneva Medical Corporation Information
    • 11.5.2 Suneva Medical Description and Business Overview
    • 11.5.3 Suneva Medical Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Suneva Medical Dermal filler and Botolinum Toxin Products Offered
    • 11.5.5 Suneva Medical Related Developments
  • 11.6 Contura
    • 11.6.1 Contura Corporation Information
    • 11.6.2 Contura Description and Business Overview
    • 11.6.3 Contura Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Contura Dermal filler and Botolinum Toxin Products Offered
    • 11.6.5 Contura Related Developments
  • 11.7 HUGEL
    • 11.7.1 HUGEL Corporation Information
    • 11.7.2 HUGEL Description and Business Overview
    • 11.7.3 HUGEL Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 HUGEL Dermal filler and Botolinum Toxin Products Offered
    • 11.7.5 HUGEL Related Developments
  • 11.8 Grex Pharma
    • 11.8.1 Grex Pharma Corporation Information
    • 11.8.2 Grex Pharma Description and Business Overview
    • 11.8.3 Grex Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Grex Pharma Dermal filler and Botolinum Toxin Products Offered
    • 11.8.5 Grex Pharma Related Developments
  • 11.9 Daewoong Pharmaceuticals
    • 11.9.1 Daewoong Pharmaceuticals Corporation Information
    • 11.9.2 Daewoong Pharmaceuticals Description and Business Overview
    • 11.9.3 Daewoong Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Daewoong Pharmaceuticals Dermal filler and Botolinum Toxin Products Offered
    • 11.9.5 Daewoong Pharmaceuticals Related Developments
  • 11.10 Medy-Tox
    • 11.10.1 Medy-Tox Corporation Information
    • 11.10.2 Medy-Tox Description and Business Overview
    • 11.10.3 Medy-Tox Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Medy-Tox Dermal filler and Botolinum Toxin Products Offered
    • 11.10.5 Medy-Tox Related Developments
  • 11.1 Allergan
    • 11.1.1 Allergan Corporation Information
    • 11.1.2 Allergan Description and Business Overview
    • 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Allergan Dermal filler and Botolinum Toxin Products Offered
    • 11.1.5 Allergan Related Developments
  • 11.12 SciVision Biotech
    • 11.12.1 SciVision Biotech Corporation Information
    • 11.12.2 SciVision Biotech Description and Business Overview
    • 11.12.3 SciVision Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 SciVision Biotech Products Offered
    • 11.12.5 SciVision Biotech Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Dermal filler and Botolinum Toxin Market Estimates and Projections by Region
    • 12.1.1 Global Dermal filler and Botolinum Toxin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Dermal filler and Botolinum Toxin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Dermal filler and Botolinum Toxin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Dermal filler and Botolinum Toxin Sales Forecast (2021-2026)
    • 12.2.2 North America: Dermal filler and Botolinum Toxin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Dermal filler and Botolinum Toxin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Dermal filler and Botolinum Toxin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Dermal filler and Botolinum Toxin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Dermal filler and Botolinum Toxin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Dermal filler and Botolinum Toxin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Dermal filler and Botolinum Toxin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Dermal filler and Botolinum Toxin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Dermal filler and Botolinum Toxin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Dermal filler and Botolinum Toxin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Dermal filler and Botolinum Toxin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Dermal filler and Botolinum Toxin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Dermal filler and Botolinum Toxin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Dermal filler and Botolinum Toxin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Dermal filler and Botolinum Toxin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Dermal filler and Botolinum Toxin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Dermal filler and Botolinum Toxin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Dermal filler and Botolinum Toxin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Dermal filler and Botolinum Toxin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Dermal filler and Botolinum Toxin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Dermal filler and Botolinum Toxin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermal filler and Botolinum Toxin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Dermal filler and Botolinum Toxin market is segmented into
    Aesthetic Volume Restoration
    Wrinkle Reduction

    Segment by Application, the Dermal filler and Botolinum Toxin market is segmented into
    Hyaluronic Acid Based Fillers
    Non-Hyaluronic Acid Based Fillers
    Botulinum Toxin

    Regional and Country-level Analysis
    The Dermal filler and Botolinum Toxin market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Dermal filler and Botolinum Toxin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Dermal filler and Botolinum Toxin Market Share Analysis
    Dermal filler and Botolinum Toxin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dermal filler and Botolinum Toxin business, the date to enter into the Dermal filler and Botolinum Toxin market, Dermal filler and Botolinum Toxin product introduction, recent developments, etc.

    The major vendors covered:
    Allergan
    Galderma
    Merz Pharma GmbH & Co. KGaA
    Anika Therapeutics
    Suneva Medical
    Contura
    HUGEL
    Grex Pharma
    Daewoong Pharmaceuticals
    Medy-Tox
    TEOXANE Laboratories
    SciVision Biotech

    Buy now